Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer
Clinical trial NCT04000295 · UNKNOWN
Trial details
- NCT number
- NCT04000295
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-16
- Primary completion
- 2021-01-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.